Liang Ma
- Hepatology top 0.5%
- Epidemiology top 2%
- Oncology top 5%
- Cancer Research top 5%
- Surgery top 5%
- Co-authors
- Jian‐Hong ZhongBang‐De XiangLe‐Qun LiWen‐Feng GongKe YangXue‐Mei YouFeixiang WuJiazhou Ye
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (60 papers)Liver Disease Diagnosis and Treatment (35 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Liang Ma
99 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 100
- Hepatology 1.6k
- Epidemiology 1.1k
- Oncology 596
- Cancer Research 545
- Surgery 538
Countries citing papers authored by Liang Ma
This map shows the geographic impact of Liang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Ma more than expected).
Fields of papers citing papers by Liang Ma
This network shows the impact of papers produced by Liang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Ma. The network helps show where Liang Ma may publish in the future.
Co-authorship network of co-authors of Liang Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Liang Ma. A scholar is included among the top collaborators of Liang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Ma. Liang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 36 | |
| 7 | 2 | |
| 8 | 42 | |
| 9 | 9 | |
| 10 | 0 | |
| 11 | 13 | |
| 12 | 226 | |
| 13 | 11 | |
| 14 | 13 | |
| 15 | 1 | |
| 16 | 39 | |
| 17 | 13 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 15 |
About Liang Ma
Liang Ma is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 104 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Liver Disease Diagnosis and Treatment (35 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers). The work is most often cited by research in Hepatology (1.6k citations), Cancer Research (545 citations) and Epidemiology (1.1k citations). Liang Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jian‐Hong Zhong, Bang‐De Xiang, Le‐Qun Li, Wen‐Feng Gong, Ke Yang, Xue‐Mei You, Le‐Qun Li, Feixiang Wu, Jiazhou Ye and Xinping Ye. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.